Genmab chief executive officer Jan van de Winkel claims there are various other alternatives if the bargain fails.
发布者：BY ALBERT RONNING-ANDERSSON，转转请注明出处：https://robotalks.cn/crucial-quarter-for-genmab-jj-must-decide-on-miracle-drug-2/
Crucial quarter for Genmab: J&J must decide on “miracle drug”
赞 (0)
关于作者
Genmab’s CEO: We’re scanning the market for acquisition opportunities to boost sales
上一篇
22 1 月, 2025 12:21 上午
Researchers put the shine on digitally rendered feathers
下一篇
22 1 月, 2025
相关推荐
-
Edge Group/SDF Backed Mayman Aerospace Showcases Autonomous Flight Tests of Turbine-Powered VTOL Aircraft at U.S. Department of Defense Airbase
LONG COASTLINE, Calif.–( COMPANY CABLE)– #RAZOR– Mayman Aerospace finishes effective examination trips of its self-governing RAZOR VTOL airplane at a United State…
-
BlueFlag Security nominata IDC Innovator per l'identità e l'accesso al ciclo di vita dello sviluppo di software
SUNNYVALE, Calif.–( COMPANY CABLE)– BlueFlag Safety and security, un leader nella sicurezza e administration del ciclo di vita dello sviluppo software application (SDLC…
-
UiPath Named a Leader in Everest Group Digital Interaction Intelligence Products PEAK Matrix® Assessment 2024
NEW YORK CITY–(SERVICE CABLE)– UiPath called a Leader in the Everest Team Digital Communication Knowledge Products Optimal Matrix ® Evaluation 2024 for the 2nd successi…
-
Fortescue’s Andrew Forrest: “Zero emissions is our future”
Liebherr technology collaboration introduced at MINExpo 2024 is effective disruptor
